| 
		
 | 
Keyword : interstitial lung disease LUNGS AND SYSTEMIC LUPUS ERYTHEMATO: A CLINICAL CASE OF THE EFFECTIVE USE OF NINTEDANIB IN THE TREATMENT OF COMMON INTERSTITIAL LUPUS PNEUMONIAAuthors: Rekalov D.G. Danyuk I.O. №96 (2) 2024 / Review: 22  Systemic scleroderma and interstitial lung disease (updated ACR 2023 guidelines)Authors: Dzhus M.B. Yatsyshyn R.I. №94 (4) 2023 / Review: 42  CLINICAL PORTRAIT OF PATIENTS WITH SYSTEMIC SCLEROSISAuthors: Yatsyshyn R.I. Cherniuk N.V. №93 (3) 2023 / Review: 39  CLINICAL CASE: DIFFICULTIES IN THE DIFFERENTIAL DIAGNOSIS OF DERMATOMYOSITIS WITH LUNG INVOLVEMENT AND COVID-19Authors: Romanovsky A.V. Levchenko V.G. №94 (4) 2023 / Review: 50  PROGRESSIVE PULMONARY FIBROSIS: THERAPEUTIC AND DIAGNOSTIC TACTICS AND A SINGLE TARGET DRUGAuthor:Polyakova Daria №89–90 (3–4) 2022 / Review: 20  FEATURES OF SYSTEMIC SCLEROSIS INDUCTION IN EXPERIMENTAL CONDITIONSAuthors: Doskaliuk B.V. Zaiats L.M. Yatsyshyn R.I. №87 (1) 2022 / Review: 43  | 
 |